Question:
The number of subjects required in a phase 1 clinical trial is:-
The number of subjects required in a phase 1 clinical trial is:-
Updated On: Aug 10, 2024
- 20 to 100
- Upto several hundred
- 300 to 3,000
- Several thousands
Hide Solution
Verified By Collegedunia
The Correct Option is A
Solution and Explanation
The correct answer is option (A) : 20 to 100
Was this answer helpful?
0
0
Top Questions on Clinical Trial Fundamentals
- When a New Drug Application (NDA) made?
- GPAT - 2023
- Clinical Pharmacy and Therapeutics
- Clinical Trial Fundamentals
- Match List I with List II
List I List II A Phase‐I I Post marketing surveillance B Phase‐0 II Micro dosing C Phase‐3 III First in human dose D Phase‐4 IV Multicentric trials
Choose the correct answer from the options given below:- GPAT - 2022
- Clinical Pharmacy and Therapeutics
- Clinical Trial Fundamentals
- To monitor the safety of the new drug under actual conditions of use in large number of patients has been classified as____ clinical trials.
- GPAT - 2021
- Clinical Pharmacy and Therapeutics
- Clinical Trial Fundamentals
- Identify phase of clinical trial having following features:
(A) Trial is conducted on about 3000 patients
(B) Purpose of trial is therapeutic confirmation
(C) Safety and tolerability is evaluated on wider scale
(D) Completion of trial is followed by New Drug Application (NDA)- GPAT - 2020
- Clinical Pharmacy and Therapeutics
- Clinical Trial Fundamentals
- Efficiency of drug is checked in modest population in
- GPAT - 2015
- GPAT - 2016
- Clinical Pharmacy and Therapeutics
- Clinical Trial Fundamentals
View More Questions
Questions Asked in GPAT exam
- Manufacturing Specification for tooling has been standardized by?
- GPAT - 2025
- Pharmacy Profession & Introduction to Pharmaceuticals
- If the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist, it is:
- GPAT - 2025
- Drug therapy
- How much volume of Raw spirit can an excise officer withdraw as sample?
- GPAT - 2025
- Indian Pharmaceutical Industry- An Overview
- Match the following:
(1) Schedule FF
(2) Schedule F3
(3) Schedule V
(4) Schedule Y
Descriptions:
(P) Standards of patent and proprietary medicines
(Q) Requirements and guidelines for clinical trials
(R) Standards for sterilized umbilical tapes
(S) Standards for Ophthalmic preparations- GPAT - 2025
- Drug therapy
- Glycogenic amino acids enter TCA cycle except:
- GPAT - 2025
- Biochemistry
View More Questions